Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J. van der Wilk, Sjoerd M. Lagarde, Camiel Rosman et al.|The Lancet Oncology|2025Cited by 95
796. P02.05 NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS STANDARD SURGERY FOR OESOPHAGEAL CANCER (SANO-TRIAL): A MULTICENTRE STEPPED-WEDGE CLUSTER-RANDOMISED NONINFERIORITY TRIALBerend Van Der Wilk, J. Jan B. van Lanschot, Ben M. Eyck et al.|Diseases of the Esophagus|2024Cited by 1